This long-overdue set of comprehensive recommendations advocates for creation of regionalized hub-and-spoke systems for care of refractory cardiogenic shock cases.
The ACCELERATE trial found no effect on cardiac events with evacetrapib despite large HDL gains and solid LDL declines. A substudy presented at ESC 2017 now shows the drug fared no better when analysis was limited to diabetic patients.
A new national database analysis shows that adult congenital heart disease is placing a large and growing burden on emergency departments. This infographic shares the data essentials at a glance.
Elevated troponin levels are associated with increased risk of death, but can that risk be modified in the postoperative setting? Cleveland Clinic has launched the INTREPID trial to find out.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Two new studies find that when bystanders use CPR and defibrillators on cardiac arrest patients before paramedics arrive, neurologically intact survival improves. But bystander intervention rates remain too low.